Abstract 1741: STAT3 Orchestrates common and divergent mechanisms in different cell types to promote pancreatic cancer development and progression
Monday O. Ogese(Cedars-Sinai Medical Center), James Turkson(Cedars-Sinai Medical Center), Stephen J. Pandol(Cedars-Sinai Medical Center), Aurelia Lugea(Cedars-Sinai Medical Center), Richard T. Waldron(Cedars-Sinai Medical Center), Yue Chen(Cedars-Sinai Medical Center), Francisco Lopez‐Tapia(Cedars-Sinai Medical Center), Benjamin Jackel(Cedars-Sinai Medical Center), Lihong Huo(Cedars-Sinai Medical Center)
Cited by 0
Related Papers
Substrate and Functional Diversity of Lysine Acetylation Revealed by a Proteomics Survey
|Molecular Cell|2006|1.5k
Acetylation Is Indispensable for p53 Activation
|Cell|2008|828
The pancreatic stellate cell: a star on the rise in pancreatic diseases
|Journal of Clinical Investigation|2007|686
STAT3 as a target for inducing apoptosis in solid and hematological tumors
|Cell Research|2008|489
Phosphotyrosyl Peptides Block Stat3-mediated DNA Binding Activity, Gene Regulation, and Cell Transformation
|Journal of Biological Chemistry|2001|437